SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001193125-22-176648
Filing Date
2022-06-17
Accepted
2022-06-17 17:19:06
Documents
6

Document Format Files

Seq Description Document Type Size
1 F-3/A d272618df3a.htm F-3/A 820436
2 EX-23.2 d272618dex232.htm EX-23.2 1634
3 EX-23.3 d272618dex233.htm EX-23.3 5347
4 GRAPHIC g272618g00g10.jpg GRAPHIC 77499
5 GRAPHIC g272618g04y63.jpg GRAPHIC 28252
6 GRAPHIC g272618g31h16.jpg GRAPHIC 6464
  Complete submission text file 0001193125-22-176648.txt   983574
Mailing Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400
Business Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400 86 512 5357 7866
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-264340 | Film No.: 221025094
SIC: 2834 Pharmaceutical Preparations